Prefilled Syringe Use Growing Across A Range Of Therapeutic Segments
Main Category: Medical DevicesAlso Included In: Immune System / Vaccines; Pharma Industry / Biotech Industry
Article Date: 21 Feb 2008 - 2:00 PDT
The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs, and healthcare administration initiatives. Population demographics and efforts by managed care providers to control healthcare costs are driving the growth in drug self-administration, particularly for chronic conditions, introducing a new class of naïve users to parenteral drug delivery. User-friendly syringe and injection device designs and the availability of an increasing number of drugs in pre-filled insertable and disposable cartridges are propelling the growth of prefilled syringes across all user segments.
Improved patient compliance, efficient delivery of high-priced biologicals, and patient & caregiver safety are key market drivers in this sector. The cost of biologicals such as recombinant proteins has created interest in prefilled syringes to reduce cost and waste associated with the handling of vial-packaged drugs. Partnerships between device designers and drug developers are an essential element in the success of prefilled devices, particularly for patient self-administration.
These findings are contained in a new and comprehensive report: Prefilled Syringes: Drugs, Devices and Disease Therapeutics. The report analyzes eleven important prefilled syringe therapeutic segments including chronic diseases such as diabetes, autoimmune disorders, and hormone replacement, as well as drugs for oncology, blood factors, reproductive health, wellness programs and vaccine administration.
About Greystone
Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.
Greystone Associates
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add to:
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2008 MediLexicon International Ltd |




